Skip to main content
SpringerLink
Log in

Medicinal Plants Used in the Treatment of Pulmonary Hypertension

  • Chapter
  • First Online:
Medicinal Plants for Lung Diseases

Abstract

Pulmonary hypertension is caused by a rise in the vascular tone thus affecting the structural composition of the pulmonary arteries. There are various symptoms that are associated with pulmonary hypertension, which includes among others, lungs inflammation, apoptosis inhibition, remodeling of pulmonary vascular and hypoxia. It has been established that the application of medicinal plant could be applied for effective management of pulmonary hypertension. Therefore, this chapter intends to provide a detailed information on some medicinal plant that could be applied for effective management of pulmonary hypertension. Detailed information on isolation, purification, and extraction of the active constituents present in plants that are utilized for the treatment of pulmonary hypertension were also highlighted. Specific techniques for structural elucidation of the active compound were also highlighted. Detailed information on the biochemical pathway involved in the activities of phytochemical in medical plant in the treatment of pulmonary hypertension as well as detailed facts on the modes of action involved in the application of medicinal treatment of pulmonary hypertension were also highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Xiang L, Li Y, Xu DX, Kosanovic D, Schermuly RT, Li X (2018) Natural plant products in treatment of pulmonary arterial Hypertension. Pulm Circ 8(3):1–20. https://doi.org/10.1177/2045894018784033

    Article  CAS  Google Scholar 

  2. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1801913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sánchez-Gloria JL, Osorio-Alonso H, Arellano-Buendía AS, Carbó R, Hernández-Díazcouder A, Guzmán-Martín CA, Rubio-Gayosso I, Sánchez-Muñoz F (2020) Nutraceuticals in the treatment of pulmonary arterial hypertension. Int J Mol Sci 21:4827. https://doi.org/10.3390/ijms21144827

    Article  CAS  PubMed Central  Google Scholar 

  4. Jasemi SV, Hosna K, Ina YA, Mohammad HF, Javier E (2020) Medicinal plants and phytochemicals for the treatment of pulmonary hypertension. Front Pharmacol 11:145. https://doi.org/10.3389/fphar.2020.00145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jasemi SV, Khazaei H, Aneva IY, Farzaei MH, Echeverria J (2020) Medicinal plants and phytochemicals for pulmonary hypertension. Front Pharmacol 11:145. https://doi.org/10.3389/fphar.2020.00145.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F (2011) Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 8(8):443. https://doi.org/10.1038/nrcardio.2011.87

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM (2001) Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 88(1):E2–E11

    Article  CAS  PubMed  Google Scholar 

  8. Dorfmüller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22(2):358–363

    Article  PubMed  Google Scholar 

  9. Balabanian K, Foussat A, Dorfmüller P, Durand-Gasselin I, Capel F, Bouchet-Delbos L, Portier A, Marfaing-Koka A, Krzysiek R, Rimaniol AC, Simonneau G, Emilie D, Humbert M (2002) CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165(10):1419–1425

    Article  PubMed  Google Scholar 

  10. Waxman AB, Zamanian RT (2013) Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies. Am J Cardiol 111(5):1–16. https://doi.org/10.1016/j.amjcard.2012.12.002

    Article  CAS  Google Scholar 

  11. Wong CM, Bansal G, Pavlickova L, Marcocci L, Suzuki YJ (2013) Reactive oxygen species and antioxidants in pulmonary hypertension. Antioxid Redox Signal 18(14):1789–1796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hui-li G (2011) The management of acute pulmonary arterial hypertension. Cardiovasc Ther 29(3):153–175. https://doi.org/10.1111/j.1755-5922.2009.00095.x

    Article  PubMed  Google Scholar 

  13. Reyes RV, Castillo-Galán S, Hernandez I, Herrera EA, Ebensperger G, Llanos AJ (2018) Revisiting the role of TRP, orai, and ASIC channels in the pulmonary arterial response to hypoxia. Front Physiol 9:486

    Article  PubMed  PubMed Central  Google Scholar 

  14. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS et al (2010) Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 122(2):164–172

    Article  PubMed  Google Scholar 

  15. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery J-L, Barbera JA et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493–2537. https://doi.org/10.1093/eurheartj/ehp297

    Article  PubMed  Google Scholar 

  16. Hussain A, Bennett RT, Tahir Z, Isaac E, Chaudhry MA, Qadri SS, Loubani M, Morice AH (2019) Differential effects of atrial and brain natriuretic peptides on human pulmonary artery: an in vitro study. World J Cardiol 11(10):236–243. https://doi.org/10.4330/wjc.v11.i10.236

    Article  PubMed  PubMed Central  Google Scholar 

  17. Mintah SO, Asafo-Agyei T, Archer MA, Atta-Adjei Junior P, Boamah D, Kumadoh D, Appiah A, Ocloo A, Boakye YD, Agyare C (2019) Medicinal plants for treatment of prevalent diseases. Intechopen. https://doi.org/10.5772/intechopen.82049

  18. Voswinckel R, Reichenberger F, Enke B et al (2008) Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension. Pulm Pharmacol Ther 21:824–832

    Article  CAS  PubMed  Google Scholar 

  19. Hoeper MM, Barberà JA, Channick RN et al (2009) Diagnosis, assessment, and treatment of non–pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 54:85–96

    Article  Google Scholar 

  20. Njila NIM, Mahdi E, Lembe MD, Nde Z, Nyonseu D (2017) Review on extraction and isolation of plant secondary metabolites. In: 7th Int’l conference on agricultural, chemical, biological and. Environ Sci 2017:67–72. https://doi.org/10.15242/IIE.C051720

    Article  Google Scholar 

  21. Fabricant DS, Farnsworth NR (2001) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109:69–75

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Cosa P, Vlietinck AJ, Berghe DV, Maes L (2006) Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’. J Ethnopharmacol 106:290–302

    Article  Google Scholar 

  23. Zhang Q, Lin GL, Ye CW (2018) Techniques for extraction and isolation of natural products: a comprehensive review. Chin Med 13(20):1–26. https://doi.org/10.1186/s13020-018-0177

    Article  PubMed  PubMed Central  Google Scholar 

  24. Rasul MG (2018) Extraction, isolation and characterization of natural products from medicinal plants. Int J Basic Sci Appl Comput 2(6):1–6

    Google Scholar 

  25. Handa SS, Khanuja SPS, Longo G, Rakesh DD (2008) Extraction technologies for medicinal and aromatic plants. ICS UNIDO, Trieste

    Google Scholar 

  26. Vidyadhar S, Saidulu M, Gopal TK, Chamundeeswari D, Rao U, Banji D (2010) In vitro anthelmintic activity of the whole plant of Enicostemma littorale by using various extracts. Int J Appl Biol Pharma Technol 1(3):1119–1125

    Google Scholar 

  27. Fan XH, Cheng YY, Ye ZL, Lin RC, Qian ZZ (2006) Multiple chromatographic fingerprinting and its application to the quality control of herbal medicines. Anal Chim Acta 555:217–224

    Article  CAS  Google Scholar 

  28. Cannell RJP (1998) Natural products isolation. Human Press Inc., Totowa, pp 165–208

    Book  Google Scholar 

  29. Tonthubthimthong SC, Douglas P, Luewisutthichat W (2011) Supercritical CO2 extraction of nimbin from neem seeds an experimental study. J Food Eng 47(4):2

    Google Scholar 

  30. Eberhardt TL, Li X, Shupe TF, Hse CY (2007) Chinese tallow tree (Sapium Sebiferum) utilization: characterization of extractives and cell-wall chemistry. Wood Fiber Sci 39:319–324

    CAS  Google Scholar 

  31. Horníčková J, Kubec R, Cejpek K, Velíšek J, Ovesna J, Stavělíková H (2010) Profiles of S-alk (en) ylcysteine sulfoxides in various garlic genotypes. Czech J Food Sci 28(4):298–308

    Article  Google Scholar 

  32. Fallon MB, Abrams GA, Abdel-Razek TT, Dai J, Chen S-J, Chen Y-F et al (1998) Garlic prevents hypoxic pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol 275(2):L283–L287. https://doi.org/10.1152/ajplung.1998.275.2.L283.

    Article  CAS  Google Scholar 

  33. Tan X, Chai J, Bi SC, Li JJ, Li WW, Zhou JY (2012) Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension. Vet J 193(2):420–425. https://doi.org/10.1016/j.tvjl.2012.01.017

    Article  CAS  PubMed  Google Scholar 

  34. Chu MP, Xu ZX, Zhang XL (2007) Changes of expression of ICAM-1 in autoimmune myocarditis in mice and the interfering effect of Panax notoginseng saponin. J Wenzhou Med Coll 37:203–205

    CAS  Google Scholar 

  35. Behnam A, Majid K, Seyed MH, Zia UR, Farmanullah F, Mohammad HK, LiGuo Y (2019) Hawthorn (Crataegus oxyacantha) flavonoid extract as an effective medicinal plant derivative to prevent pulmonary hypertension and heart failure in broiler chickens. Kafkas Univ Vet Fak Derg 25(3):321–328. https://doi.org/10.9775/kvfd.2018.20930

    Article  Google Scholar 

  36. Himanshu M, Pankaj P, Soheb AM, Sandeep S, Milind PH, Sanjay KB, Sudheer A, Ruma R, Subir KM (2016) Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), an Ayurvedic drug in experimental pulmonary hypertension. J Ethnopharmacol. https://doi.org/10.1016/j.jep.2016.07.029

  37. Masoumeh P, Reza M, Saber A, Nasrollah N, Siamak N, Fariba B (2017) Medicinal plants used for hypertension. J Pharm Sci Res 9(5):537–541

    Google Scholar 

  38. Jiang YB, Yang YR (2015) Trifolium pratense isoflavones improve pulmonary vascular remodelling in broiler chickens. J Anim Physiol Anim Nutr. https://doi.org/10.1111/jpn.12424.1-10

  39. Landazuri P, Chamorro NL, Cortes BP (2017) Medicinal plants used in the management hypertension. J Anal Pharm Res 5(2):00134. https://doi.org/10.15406/japlr.2017.05.00134.

    Article  Google Scholar 

  40. Gan H (2010) The management of acute pulmonary arterial hypertension. Cardiovasc Ther 29(2011):153–175. https://doi.org/10.1111/j.1755-5922.2009.00095.x

    Article  Google Scholar 

  41. Ritu S, Sakshi J, Jyoti KB, Parul S (2016) The use of rauwolfia serpentina in hypertensive patients. IOSR J Biotechnol Biochem 2(5):28–32

    Google Scholar 

  42. Lili X, Ying L, Xu D, Djuro K, Ralph TS, Xiaohui L (2018) Natural plant products in treatment of pulmonary arterial hypertension. Pulm Circ 8(3):1–20. https://doi.org/10.1177/2045894018784033.

    Article  Google Scholar 

  43. Meresa A, Fekadu N, Degu S, Tadele A, Geleta B (2017) An ethno botanical review on medicinal plants used for the management of hypertension. Clin Exp Pharmacol 7:228. https://doi.org/10.4172/2161-1459.1000228.

    Article  Google Scholar 

  44. Lakshmi T, Anitha R, Durgha K, Manjusha V (2011) Coping with hypertension using safer herbal medicine – a therapeutic review. Int J Drug Dev Res 3(3):31–57

    Google Scholar 

  45. Qilian H, Xingmei N, Silin L, Shanshan S, Ke M, Zhanqiang L, Dianxiang L, Rili G (2018) Tsantan sumtang alleviates chronic hypoxia-induced pulmonary hypertension by inhibiting proliferation of pulmonary vascular cells. Biomed Res Int 2018:9504158. https://doi.org/10.1155/2018/9504158

    Article  CAS  Google Scholar 

  46. Zhouye W, Zhaoqing X (2020) Compound xiebai capsule alleviates pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats. Trop J Pharm Res 19(1):107–114

    Article  Google Scholar 

  47. Tingting W, Jun H, Wenjing X, Yaolei Z, Longfu Z, Li Y, Xiaoqiang Y, Xin C, Yonghe H (2020) Chinese medicinal plants for the potential management of high-altitude pulmonary oedema and pulmonary hypertension. Pharm Biol 58(1):815–827. https://doi.org/10.1080/13880209.2020.1804407.

    Article  Google Scholar 

  48. Manish A, Nandini D, Vikas S, Chauhan NS (2010) Herbal remedies for treatment of hypertension. IJPSR 1(5):1–21

    Google Scholar 

  49. Thomas FMK, Michael H, Heinrich W, Hagen K, Raimund E (2005) Clinical und pharmacological testing of patients with pulmonary hypertension for treatment decision. Herz 30:286–295. https://doi.org/10.1007/s00059-005-2699-0.

    Article  Google Scholar 

  50. Rakotomalala G, Agard C, Tonnerre P, Tesse A, Derbré S, Michalet S, Hamzaoui J, Rio M, Cario-Toumaniantz C, Richomme P, Charreau B, Loirand G, Pacaud P (2013) Extract from Mimosa pigra attenuates chronic experimental pulmonary hypertension. J Ethnopharmacol 148(1):106–116. https://doi.org/10.1016/j.jep.2013.03.075

    Article  CAS  PubMed  Google Scholar 

  51. Bai MK, Guo Y, Bian BD et al (2011) Integripetal rhodiola herb attenuates high altitude-induced pulmonary arterial remodeling and expression of vascular endothelial growth factor in rats. Sheng Li Xue Bao 63:143–148

    PubMed  Google Scholar 

  52. Huang XY, Fan R, Lu YY, Lin QD (2011) The protective effect of salidroside on cor pulmonale rats induced by chronic hypoxia in normal pressure. Chin Arch Tradit Chin Med 29:1868–1871

    CAS  Google Scholar 

  53. Zhang S, Gao W, Xu K et al (1999) Early use of Chinese drug rhodiola compound for patients with post-trauma and inflammation in prevention of ALI/ARDS. Zhonghua Wai Ke Za Zhi 37:238–240

    CAS  PubMed  Google Scholar 

  54. Wang XQ, Wang BH, Li YH, Zhao YL, Wang YY, Wang Y (2012) Regulating effect and its mechanism of Tibet Rhodiola crenulate on blood pressure in spontaneous hypertension rat. Chin J Exp Trad Med Form 18:150–154

    CAS  Google Scholar 

  55. Sui XL, Yang F, Chen RH et al (2006) Inhibition of rhodiola on the growth of EVC-304 cell line. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 22:524–525

    PubMed  Google Scholar 

  56. Yao BW, Chen W (2005) Research advances in the pharmacological effects of Ginkgo biloba leaves (in Chinese). Zhejiang J Integr Tradit Chin West Med 15:192–193

    Google Scholar 

  57. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, Crozier A, Sandström B, Dragsted LO (1999) Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 69:87–94

    Article  CAS  PubMed  Google Scholar 

  58. Tulsulkar J, Shah ZA (2013) Ginkgo biloba prevents transient global ischemia–induced delayed hippocampal neuronal death through antioxidant and anti–inflammatory mechanism. Neurochem Int 62:189–197

    Article  CAS  PubMed  Google Scholar 

  59. Li JW, Chen P, Guan XQ et al (2008) Inhibition of Puerarin on pulmonary hypertension in rats with hypoxia and hypercapnia. Zhongguo Zhong Yao Za Zhi 33:544–549

    CAS  PubMed  Google Scholar 

  60. Qu HL, Li XY, Wang FY et al (2004) Effect of Polydatin on hypoxic pulmonary hypertension (in Chinese). J Binzhou Med Coll 27:328–329

    Google Scholar 

  61. Wei L, Liu T, Liu B et al (2007) Effect of triptolide on the expression of MMP9/TIMP-1 in the lung of expression pulmonary hypertension. Med J 28:828–830

    CAS  Google Scholar 

  62. Han C, Qi J, Gao S, Li C, Ma Y, Wang J et al (2017) Vasodilation effect of volatile oil from Allium macrostemon Bunge are mediated by PKA/NO pathway and its constituent dimethyl disulfide in isolated rat pulmonary arterials. Fitoterapia 120:52–57. https://doi.org/10.1016/j.fitote.2017.05.007.

    Article  CAS  PubMed  Google Scholar 

  63. Ahmadipour B, Hassanpour H, Asadi E, Khajali F, Rafiei F, Khajali F (2015) Kelussia odoratissima Mozzaf – A promising medicinal herb to prevent pulmonary hypertension in broiler chickens reared at high altitude. J Ethnopharmacol 159(1):49–54

    Article  PubMed  Google Scholar 

  64. Wisutthathum S, Demougeot C, Totoson P, Adthapanyawanich K, Ingkaninan K, Temkitthawon P et al (2018) Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension. Phytomedicine 50:157–165. https://doi.org/10.1016/j.phymed.2018.05.014.

    Article  CAS  PubMed  Google Scholar 

  65. Nan X, Su S, Ma K, Ma X, Wang X, Zhaxi D et al (2018) Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. J Ethnopharmacol 216:175–183. https://doi.org/10.1016/j.jep.2018.01.010.

    Article  CAS  PubMed  Google Scholar 

  66. Kim YS, Cha JM, Kim D, Lee TH (2018) A new steroidal glycoside from Allium macrostemon Bunge. Nat Prod Sci 24(1):54. https://doi.org/10.20307/nps.2018.24.1.54.

    Article  CAS  Google Scholar 

  67. Hornickova J, Kubec R, Cejpek K, Velisek J, Ovesna J, Stavelikova H (2010) Profile of S-alk (en) ylcysteine sulfoxides in Various garlic genotypes. Czech J Food Sci 28(4):298–308

    Article  CAS  Google Scholar 

  68. Meghwani H, Prabhakar P, Mohammed SA, Seth S, Hote MP, Banerjee SK et al (2017) Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension. J Ethnopharmacol 197:184–194. https://doi.org/10.1016/j.jep.2016.07.029.

    Article  PubMed  Google Scholar 

  69. Wang RX, He RL, Jiao HX, Dai M, Mu YP, Hu Y et al (2015) Ginsenoside Rb1 attenuates agonist-induced contractile response via inhibition of store-operated calcium entry in pulmonary arteries of normal and pulmonary hypertensive rats. Cell Physiol Biochem 35(4):1467–1481. https://doi.org/10.1159/000373966.

    Article  CAS  PubMed  Google Scholar 

  70. Yuan L-B, Hua C-Y, Gao S, Yin Y-L, Dai M, Meng H-Y et al (2017) Astragalus polysaccharides attenuate monocrotaline-induced pulmonary arterial hypertension in rats. Am J Chin Med 45(04):773–789. https://doi.org/10.1142/S0192415X17500410.

    Article  CAS  PubMed  Google Scholar 

  71. Luo J, Gu Y, Liu P, Jiang X, Yu W, Ye P et al (2018) Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro. J Cell Physiol 233(12):9750–9762. https://doi.org/10.1002/jcp.26940

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Applied Microbiology, Biotechnology and Nanotechnology Laboratory, Department of Microbiology, Edo State University Uzairue, Iyamho, Edo State, Nigeria

    Charles Oluwaseun Adetunji

  2. Laboratory for Reproductive Biology and Developmental Programming, Department of Physiology, Edo State University Uzairue, Iyamho, Edo State, Nigeria

    Olugbemi Tope Olaniyan

  3. Department of Eastern Medicine, Government College University, Faisalabad, Pakistan

    Muhammad Akram & Fahad Said Khan

  4. Department of Biochemistry, Edo State University Uzairue, Iyamho, Edo State, Nigeria

    Olulope Olufemi Ajayi

  5. Department of Chemistry, Edo State University Uzairue, Iyamho, Edo State, Nigeria

    Abel Inobeme

  6. Nutrition and Toxicology Research Laboratory, Department of Biochemistry, Osun State University, Osogbo, Nigeria

    Seyi Olaniyan & Juliana Bunmi Adetunji

Authors
  1. Charles Oluwaseun Adetunji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olugbemi Tope Olaniyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muhammad Akram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Olulope Olufemi Ajayi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abel Inobeme
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seyi Olaniyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fahad Said Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Juliana Bunmi Adetunji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles Oluwaseun Adetunji .

Editor information

Editors and Affiliations

  1. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia

    Kamal Dua

  2. Discipline of Medical Sciences, School of Science, Western Sydney University, Sydney, NSW, Australia

    Srinivas Nammi

  3. NICM Health Research Institute, Western Sydney University, Sydney, NSW, Australia

    Dennis Chang

  4. Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

    Dinesh Kumar Chellappan

  5. School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India

    Gaurav Gupta

  6. Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia

    Trudi Collet

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Adetunji, C.O. et al. (2021). Medicinal Plants Used in the Treatment of Pulmonary Hypertension. In: Dua, K., Nammi, S., Chang, D., Chellappan, D.K., Gupta, G., Collet, T. (eds) Medicinal Plants for Lung Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-33-6850-7_14

Download citation

Publish with us

Policies and ethics

Search

Navigation